Trailing-twelve-month (TTM) revenue is $421.71 Million with a year-over-year growth of +11.99%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2026Period ended 2025-10-31 | $100,738,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-12-09 |
| Q4 FY2026Period ended 2026-01-31 | $106,242,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-03-25 |
| Q1 FY2027Period ended 2026-04-30 | $105,494,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-06-03 |
| Q2 FY2027Period ended 2026-07-31 | $109,237,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-09-09 |
| TTM revenue | $421,711,000 |
Current P/S: $653,402,866 market capitalization ÷ $421,711,000 TTM revenue = 1.55x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T16:09:59.000Z. Latest revenue period ended 2026-07-31.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2027 (2026-07-31): $109.24M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T16:11:16.029Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2026-01-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2026-01-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20212021-01-31 · USD | FY20222022-01-31 · USD | FY20232023-01-31 · USD | FY20242024-01-31 · USD | FY20252025-01-31 · USD | FY20262026-01-31 · USD |
|---|---|---|---|---|---|---|
| Product | $187M | $210M | $98M | $114M | $126M | $162M |
| Professional Services And Other | $66M | $62M | $38M |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20212021-01-31 · USD | FY20222022-01-31 · USD | FY20232023-01-31 · USD | FY20242024-01-31 · USD | FY20252025-01-31 · USD | FY20262026-01-31 · USD |
|---|---|---|---|---|---|---|
| Americas | N/A | N/A | N/A | N/A | N/A | $24M |
| Asia Pacific | $12M | $13M | $8M |
$421.71M
$421.71 Million
+11.99%
vs. $376.56M a year ago (TTM)
(2.05%)
5 Year compound annual growth rate
1 Year
+11.99%
3 Year
+12.67%
5 Year
(2.05%)
10 Year
(43.47%)
15 Year
+26.59%
20 Year
+20.12%
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2026 | $400.04M | +$49.41M | +14.09% |
| 2025 | $350.63M | +$37.23M | +11.88% |
| 2024 | $313.40M | +$1.34M | +0.43% |
| 2023 | $312.06M | ($161.98M) | (34.17%) |
| 2022 | $474.04M | +$30.58M | +6.90% |
| 2021 |
TTM Growth
+11.99%
3-Year CAGR
+12.67%
5-Year CAGR
(2.05%)
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-10-06T16:11:16.029Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| $44M |
| $51M |
| Technology Service | $190M | $202M | $176M | $165M | $181M | $188M |
|---|
| $12M |
| $14M |
| $20M |
| EMEA | N/A | N/A | N/A | N/A | N/A | $357M |
|---|
| GERMANY | $87M | $63M | $44M | $53M | $54M | $58M |
|---|
| ISRAEL | $274M | $328M | $202M | $215M | $243M | $279M |
|---|
| Other Americas Region | $7M | $18M | $10M | $7M | $7M | $8M |
|---|
| Other EMEA Region | $19M | $14M | $13M | $15M | $19M | $20M |
|---|
| UNITED STATES | $45M | $38M | $35M | $10M | $14M | $15M |
|---|
| $443.46M |
| ($13.65M) |
| (2.99%) |
| 2020 | $457.11M | +$23.65M | +5.46% |
| 2019 | $433.46M | +$377.14M | +669.69% |
| 2018 | $56.32M | +$29.79M | +112.30% |
| 2015 | $26.53M | +$9.42M | +55.05% |
